Evidence map›Paper›PMID 37625109›Full record

ArticleJournal of the American Chemical Society2023

Chemoenzymatic Synthesis of 13-Oxoverruculogen.

Jun Yang, Brandon Singh, Gabriel Cohen, Chi P Ting

Open access · greenAbstract read
In one paragraph

Article in Journal of the American Chemical Society, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
3.9field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Enzymatic Peroxidation in the Chemoenzymatic Synthesis of 13-Oxoverruculogen.Synlett : accounts and rapid communications in synthetic organic chemistry · 2025
    Article
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Jun YangBrandeis University, Edison-Lecks Laboratory, Waltham, Massachusetts 02453, United States.ORCID 0000-0002-0581-6573
Brandon SinghBrandeis University, Edison-Lecks Laboratory, Waltham, Massachusetts 02453, United States.ORCID 0009-0001-7895-0079
Gabriel CohenBrandeis University, Edison-Lecks Laboratory, Waltham, Massachusetts 02453, United States.
Chi P TingBrandeis University, Edison-Lecks Laboratory, Waltham, Massachusetts 02453, United States.ORCID 0000-0003-1386-1902
Brandeis University · US

Funding

Macromolecular Structure MechanismT32GM007596 · NIGMS · BRANDEIS UNIVERSITY · PI OPRIAN, DANIEL D · 1985 to 2019
$4.5M
Macromolecular Structure, Dynamics, and MechanismT32GM135126 · NIGMS · BRANDEIS UNIVERSITY · PI JEFF GELLES, Douglas Lowell Theobald · 2020 to 2026
$2.1M
A 400 MHz NMR SpectrometerS10OD034395 · OD · BRANDEIS UNIVERSITY · PI KRAUSS, ISAAC JONATHAN · 2023 to 2023
$482k
NIGMS NIH HHS T32 GM007596NIGMS NIH HHS T32 GM135126NIH HHS S10 OD034395
6 · The paper itself

Abstract

Verruculogens are rare fumitremorgin alkaloids that contain a highly unusual eight-membered endoperoxide. In this paper, we report a concise chemoenzymatic synthesis of 13-oxoverruculogen using enzymatic C-H peroxidation and rhodium-catalyzed C-C bond activation reactions to install the eight-membered endoperoxide and the pentacyclic core of the natural product, respectively. Our strategy involves the use of 13-

Indexed as

Biological ProductsRhodiumBiocatalysisBiological ProductsRhodium

Identifiers

PMID37625109
PMCPMC12581595
OpenAlexW4386156215

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.